Selecting which medication may be best for your patients with osteoarthritis may not be as difficult as in the past thanks to a new guide for clinicians developed by the Agency for Healthcare Research and Quality's Effective Health Care Program.
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
New AHRQ Resources
Guides Help Point to Arthritis Drugs
By News Staff
"Choosing Non-Opioid Analgesics for Osteoarthritis" employs confidence ratings based on a systematic review of the literature to grade the effectiveness and side effects of many osteoarthritic drugs, such as acetaminophen, non-steroidal anti-inflammatory drugs, or NSAIDs, and others.
The clinician guide may be downloaded at no cost (PDF file: 4 pages / 412 KB. More about PDFs.) and includes guides suggesting drug efficacy based on age, demographics, and predisposition toward cardiovascular, liver or renal disease or gastrointestinal bleeding.
AHRQ offers a similar resource for patients with osteoarthritis. "Choosing Pain Medication for Osteoarthritis" uses nonclinical language to discuss available evidence on both prescription and over-the-counter drugs and the latest scientific evidence on osteoarthritic pain relief.
The patient guide is available online (PDF file: 12 pages / 592 KB. More about PDFs.) and addresses
AHRQ offers a similar resource for patients with osteoarthritis. "Choosing Pain Medication for Osteoarthritis" uses nonclinical language to discuss available evidence on both prescription and over-the-counter drugs and the latest scientific evidence on osteoarthritic pain relief.
The patient guide is available online (PDF file: 12 pages / 592 KB. More about PDFs.) and addresses
- the benefits of specific over-the-counter pain relievers, including acetaminophen, glucosamine and skin creams;
- the benefits of specific prescription pain relievers, including NSAIDs, COX-2 inhibitors and salicylates;
- the risks of pain relievers, including symptoms of stomach bleeding, heart attack, and liver and kidney damage;
- weighing risks versus benefits; and
- cost comparison charts, including generic versus brand name drug pricing.
Making Care More Effective
AHRQ's Effective Health Care program exists to allow providers, patients and policymakers to share in making informed decisions that promote good health care by synthesizing, generating and translating research into practical knowledge.
Stay in the loop and share your opinions about the latest AHRQ research by viewing works in progress, signing up for the e-mail list, suggesting research topics and offering feedback on draft reports.
Stay in the loop and share your opinions about the latest AHRQ research by viewing works in progress, signing up for the e-mail list, suggesting research topics and offering feedback on draft reports.
The guide does not discuss nonmedical options to reduce osteoarthritic pain, such as weight loss, acupuncture, surgery and exercise. Neither the clinician nor the patient guide discusses opiate options.
Although the osteoarthritis guides may be downloaded for free online, print copies also are available by calling (800) 358-9295 and referring to AHRQ publication 06(07)-EHC009-3 for the clinician's guide or 06(07)-EHC009-2A for the patient's guide.
Although the osteoarthritis guides may be downloaded for free online, print copies also are available by calling (800) 358-9295 and referring to AHRQ publication 06(07)-EHC009-3 for the clinician's guide or 06(07)-EHC009-2A for the patient's guide.
Share this on AAFP Connection
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Health of the Public
Study: PPI Does Not Routinely Improve Asthma Control
Recalled Oral Contraceptives Pose Pregnancy Risk
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
Novartis Manufacturing Plant Closes After Drug Mix-ups
FDA Announces Classwide REMS for TIRF Medications
New Infants' Acetaminophen Products Hit Store Shelves
Avoid Environmental Factors Linked to Breast Cancer
Risk for Thrombosis Prompts REMS for Rivaroxaban
Common Drugs Implicated in Most Emergency Hospitalizations
CDC Launches Campaign for Child Medication Safety
HHS Blocks Expanded OTC Access to Plan B
Push Is On to Vaccinate Pregnant, Postpartum Women
FDA Committee Votes to Broaden PCV13 Indication
AAFP Foundation Program Aims to Fight Chronic Disease
NIAAA Alcohol Screening Guide Targets Teens
Walgreens, AAFP Launch Flu Vaccine Pilot in Five States
Helping Patients Quit Smoking Starts With a Question
Trilipix Efficacy in Question, Says FDA
USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening
AAFP Endorses ACP Guideline on ED
ACIP Recommends Expanded HPV, Hepatitis B Vaccination
Bacterial Contamination Spurs Nasal Spray Recall
CDC Renews Call for PCV13 Vaccination
USPSTF Recommends Against PSA Screening
AAFP Supports HHS' Million Hearts Initiative
FDA Phases Out Primatene Mist Inhalers
AHRQ Guides Explain Benefits, Risks of GERD Treatments
Office Champions Project Nets Smoking Cessation Gains
Multiple Lots of Oral Contraceptives Recalled
New Vaccine Review Finds Few Adverse Events
HPV Vaccination Rates Still Lag, Says CDC
Renal Injury Prompts Reclast Label Changes
High-dose Citalopram Linked to Abnormal Heart Rhythms
AHRQ Sleep Apnea Guides Review Diagnosis, Management
Board Chair Spotlights Breadth of Family Medicine Training
USPSTF Softens Stance on Bladder Cancer Screening
HHS Expands Coverage for Women's Preventive Services
Teledermatology Project Aids Underserved Patients